ICAM1 and inflammatory response: Under a low dosage (300 mg/kg), it could decrease diabetic vascular inflammation by reducing leukocyte–endothelium interaction and inhibiting the expression of intercellular adhesion molecule 1 (ICAM-1) and pro-oxidant NADPH oxidase (NOX2) in a diabetic rat model [58].